CollPlant Biotechnologies (CLGN) Cash from Operations (2018 - 2026)

CollPlant Biotechnologies has reported Cash from Operations for 9 years, with the latest figure at 3049000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 161.27% year-over-year to 3049000.0; the trailing twelve-month figure through Mar 2026 stood at 11301000.0 (up 5.88% YoY), and the FY2025 full-year result was 9419000.0, up 33.17% from the prior year.
• Cash from Operations for Q1 2026 stood at 3049000.0, down from 2935000.0 in the prior quarter.
• The five-year high for Cash from Operations was 6776000.0 in Q3 2023, with the low at 13698000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 3139647.06 across 5 years, with a median of 3212000.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Operations slumped 466.03% — and 2023, when it surged 312.75%.
• CollPlant Biotechnologies' Cash from Operations stood at 13698000.0 in 2022, then soared by 82.88% to 2345000.0 in 2023, then slumped by 47.72% to 3464000.0 in 2024, then advanced by 15.27% to 2935000.0 in 2025, then dropped by 3.88% to 3049000.0 in 2026.
• The last three Cash from Operations figures came in at 3049000.0 (Q1 2026), 2935000.0 (Q4 2025), and 2877000.0 (Q3 2025), per Business Quant data.